Comparison of rat and rabbit embryo–fetal developmental toxicity data for 379 pharmaceuticals: on the nature and severity of developmental effects

Abstract excerpt

Regulatory non-clinical safety testing of human pharmaceuticals typically requires embryo-fetal developmental toxicity (EFDT) testing in two species (one rodent and one non-rodent). The question has been raised whether under some conditions EFDT testing could be limited to one species, or whether the testing in a second species could be decided on a case-by-case basis. As part of a consortium initiative, we built...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Effects and risks of endocrine disrupting chemicals
• Share to Pharmaceutical studies and practices
• Share to Pluripotent Stem Cells Research